Lev Khondo

Title: Lev Khondo: Innovator in Pharmaceutical Compositions

Introduction

Lev Khondo is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of azithromycin compositions. His work is essential for improving the efficacy and shelf-life of this important antibiotic.

Latest Patents

Lev Khondo holds a patent for "Stabilized azithromycin compositions." This patent describes compositions and methods for stabilizing azithromycin by incorporating an antioxidant. The intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant enhances the resistance of azithromycin to degradation. The preferred methods for achieving this admixture include coprecipitation or co-milling. Additionally, the patent outlines pharmaceutical formulations that utilize stabilized azithromycin compositions and methods for their production.

Career Highlights

Lev Khondo is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva focuses on developing innovative solutions that enhance the stability and effectiveness of pharmaceutical products. His contributions are vital in ensuring that medications remain effective for longer periods.

Collaborations

Lev Khondo collaborates with Ruth Tenengauzer, who is also involved in pharmaceutical innovations. Their partnership exemplifies the collaborative spirit in the field of research and development.

Conclusion

Lev Khondo's work in stabilizing azithromycin compositions represents a significant advancement in pharmaceutical science. His innovative approach not only improves the stability of essential medications but also contributes to better patient outcomes.